Heart Failure Health Center

Heart-Failure Treatment by Device

The Future of Device Treatment continued...

In the use of device therapy, two things are certain: The next decade will bring a slew of new devices for heart-failure treatment and they will be considerably smaller and more refined than the ones now available.

"I think we've really entered the era of devices in heart failure," says Bristow. "And I think there will be rapid progress on multiple fronts in the next five to ten years."

Originally published April 2003.

Medically updated Sept. 30, 2004.

SOURCES: Bristow, M. The New England Journal of Medicine, May 20, 2004; vol 350: pp 2140-2150. Susan J. Bennett, DNS, RN, Professor in the School of Nursing, Indiana University, Indianapolis; affiliated scientist, Indiana University Center for Aging Research. Michael R. Bristow, MD, PhD, University of Colorado Health Sciences Center, Denver, Colorado; co-chair of the COMPANION study. Jay N. Cohn, MD, Professor, Cardiovascular Division in the Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota; past president of the Heart Failure Society of America. Marvin A. Konstam, MD, Chief of Cardiology, New England Medical Center; Director of Cardiovascular Development, Tufts-New England Medical Center; President of the Heart Failure Society of America.Bertram Pitt, MD, Professor of Internal Medicine, University of Michigan; Principal Investigator for EPHESUS and RALES trials. Eric A. Rose, MD, Chairman of the Department of Surgery, Columbia University College of Physicians and Surgeons; Surgeon-in-Chief, Columbia Presbyterian Medical Center, New York-Presbyterian Hospital; principal investigator for REMATCH trial. John Watson, MD, Director of the Clinical and Molecular Medicine Program in the National Heart, Lung and Blood Institute's Division of Heart and Vascular Diseases; project officer for the REMATCH trial.